Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cevayir Coban

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Immunology|August 22, 2020
The host targeting effect of chloroquine in malariaCevayir Coban
International Immunology|January 5, 2018
Unforeseen pathologies caused by malariaMichelle Sue Jann Lee, Cevayir Coban
Advances in Experimental Medicine and Biology|January 5, 2010
Immune interventions of human diseases through toll-like receptorsCevayir Coban, Ken J Ishii, Shizuo Akira
Journal of Clinical Immunology|December 29, 2005
Manifold mechanisms of Toll-like receptor-ligand recognitionKen J Ishii, Cevayir Coban, Shizuo Akira
International Reviews of Immunology|April 11, 2013
Particulate adjuvant and innate immunity: past achievements, present findings, and future prospectsEtsushi Kuroda, Cevayir Coban, Ken J Ishii
Current Opinion in Virology|April 29, 2026
TANK-binding kinase 1 (TBK1): unexpected cell type-specific immune regulation beyond antiviral type I interferon signalingMariana S Almeida, Jelena S Bezbradica, Cevayir Coban
Cytokine|August 13, 2008
Innate immune response to viral infectionShohei Koyama, Ken J Ishii, Cevayir Coban, et al.
Expert Review of Vaccines|July 14, 2010
TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccineCevayir Coban, Toshihiro Horii, Shizuo Akira, et al.
International Immunology|August 30, 2025
Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemicsNiloufar Kavian, Kouji Kobiyama, Ken J Ishii, et al.
Nature Reviews. Immunology|January 16, 2018
Tissue-specific immunopathology during malaria infectionCevayir Coban, Michelle Sue Jann Lee, Ken J Ishii
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Immunology|August 22, 2020
The host targeting effect of chloroquine in malariaCevayir Coban
International Immunology|January 5, 2018
Unforeseen pathologies caused by malariaMichelle Sue Jann Lee, Cevayir Coban
Advances in Experimental Medicine and Biology|January 5, 2010
Immune interventions of human diseases through toll-like receptorsCevayir Coban, Ken J Ishii, Shizuo Akira
Journal of Clinical Immunology|December 29, 2005
Manifold mechanisms of Toll-like receptor-ligand recognitionKen J Ishii, Cevayir Coban, Shizuo Akira
International Reviews of Immunology|April 11, 2013
Particulate adjuvant and innate immunity: past achievements, present findings, and future prospectsEtsushi Kuroda, Cevayir Coban, Ken J Ishii
Current Opinion in Virology|April 29, 2026
TANK-binding kinase 1 (TBK1): unexpected cell type-specific immune regulation beyond antiviral type I interferon signalingMariana S Almeida, Jelena S Bezbradica, Cevayir Coban
Cytokine|August 13, 2008
Innate immune response to viral infectionShohei Koyama, Ken J Ishii, Cevayir Coban, et al.
Expert Review of Vaccines|July 14, 2010
TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccineCevayir Coban, Toshihiro Horii, Shizuo Akira, et al.
International Immunology|August 30, 2025
Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemicsNiloufar Kavian, Kouji Kobiyama, Ken J Ishii, et al.
Nature Reviews. Immunology|January 16, 2018
Tissue-specific immunopathology during malaria infectionCevayir Coban, Michelle Sue Jann Lee, Ken J Ishii
Pageof 10